OurCrowd Recognized as Most Active Venture Investor in Israel, Once Again: 68 Exits to Date

Online investment platform OurCrowd has once again been recognized as the most active venture investor in Israel – which remains a hot startup market. OurCrowd noted that this is the 11th year in a row that it has been recognized as Israel’s most active venture investor by the Startup Nation Central’s Annual Report.

In an update shared by OurCrowd, the company reported participating in 77 funding rounds in 2024, including 25 first-time investments. OurCrowd typically invests in an early-stage firm and then works with the company to help ensure its success.

OurCrowd has once again been recognized as the most active venture investor in Israel Click to Tweet

While highly active in Israel, OurCrowd also lists securities from issuers around the world, like Databricks and Groq. Individual investors (Accredited) may participate in these private securities offerings at a lower entry point than is typical, frequently alongside well-known venture capitalists.

Israel has experienced several difficult years. The terrorist invasion by Hamas happened during a challenging global venture market. Yet in 2024, venture investing in Israel increased by 31% from 2023 – raising $12.2 billion.

While offering single issuer investments, OurCrowd highlights its 11 venture funds launched in 2024, including the new Israel Resilience Fund, which has backed more than 40 firms impacted by the war, raising over $100 million. In total, OurCrowd offers 58 funds for investors.

OurCrowd partnered with AI chip maker NVIDIA on an AI fund that has backed 15 different early-stage artificial intelligence firms.

To date, OurCrowd reports having booked 68 exits, including IPOs and acquisitions. An investment platform provides little value for investors unless it has a track record of delivering returns for investors.

During 2024, OurCrowd reports having participated in three exits, including the sale of transmitral valve company Innovative Bio Medical to Edwards Lifesciences for $300 million.

OurCrowd founder and CEO Jon Medved shared that some people were concerned that Israel’s innovation ecosystem would “fall apart” because of the war. This did not happen.

“Israeli readiness to embrace innovation, even when it seems somewhat risky, is a long-standing trait that is key to our sector thriving even in wartime – and crucial to its flourishing in the years to come. OurCrowd remains Israel’s most active venture investor, making significant investments in innovative startups both at home and abroad during a challenging period. The fact that Israel continues to grow its tech sector during war is sort of a core element of who we are, and our commitment to supporting this ecosystem is rock solid.”

OurCrowd reports over 240,000 registered individuals from 195 different countries and around $2.3 billion in investor commitments.



Sponsored Links by DQ Promote

 

 

 
Send this to a friend